Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 4.93 Billion | USD 10.35 Billion | 8.6% | 2023 |
According to the report published by Zion Market Research, the global Anti-Infective Vaccines Market size was valued at USD 4.93 Billion in 2023 and is predicted to reach USD 10.35 Billion by the end of 2032. The market is expected to grow with a CAGR of 8.6% during the forecast period. The report analyzes the global Anti-Infective Vaccines Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Anti-Infective Vaccines industry.
With the help of the drugs, anti-infective, and antiviral agents, the infectious diseases are treated. These agents are coupled with the boosters. In order to avoid the rapid spread of the infectious diseases, the healthcare organizations take the preventive measure of giving the anti-infective vaccines.
There are several types of infectious diseases that are spread out in the world. Some of the common infectious diseases along with its vaccine is given as follows for hepatitis Havrix, Recombivax HB, and Engerix-B is given. For polio IPOL vaccine; for influenza Fluzone, Fluarix, and FluMist vaccines; for tuberculosis BCG; and for malaria RTS,S vaccine is given.
The global market for the anti-infective vaccines is fragmented into its product, disease type, and distribution channel.
On the basis of the product, the market is segregated into inactivated vaccines, conjugate vaccines, live/attenuated vaccines, DNA and the recombinant vector vaccines, subunit vaccines, and toxoid vaccines.
On the basis of the type of thrket ise disease, the market is categorized into bacterial diseases, viral diseases, and other diseases. On the basis of the distribution channel, the ma divided into public hospitals, retail pharmacy stores and drug stores, hospitals clinics, private clinics, and e-commerce.
The major factors that are favoring the growth of the anti-infective vaccines market are the growing cases of the infectious diseases, increasing rate of emergence of new diseases, gaining resistance to the existing anti-infective therapies, and bioterrorism. The others factors that contribute to the growth of the market are increase in the awareness among the people about the infectious diseases, growing health conscious population, the developments that are made in the medical sector, and the increasing requirement to control the spread of the infectious diseases. There are some factors that limit the growth of the market which includes high cost of the immunization vaccines and the unavailability of the anti-infective vaccines in the regions that are underdeveloped.
Report Attributes | Report Details |
---|---|
Report Name | Anti-Infective Vaccines Market |
Market Size in 2023 | USD 4.93 Billion |
Market Forecast in 2032 | USD 10.35 Billion |
Growth Rate | CAGR of 8.6% |
Number of Pages | 220 |
Key Companies Covered | Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., Inc., MedImmune LLC, Novartis Vaccines and Diagnostics Ltd., Intercell Biomedical, MassBiologics, Barr Labs, Inc., Organon Teknika Co., GlaxoSmithKline Biologicals, CSL Ltd., ID Biomedical Co., Protein Sciences Co., Wyeth Pharmaceuticals, Inc., and Berna Biotech, Ltd |
Segments Covered | By product, By disease type, By distribution channel and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The region that is dominating the anti-infective vaccines market is North America. The factors that are contributing to the market growth in the North American region are the increasing purchasing power of the population in order to purchase expensive vaccines and the existence of the favorable reimbursement policies. It is expected that the Middle East and Africa and the Asia Pacific regions will witness a healthy market growth in the coming years owing to the increased expenditure on the national healthcare and the increasing focus on the prevention of the spread of the contagious diseases.
The key market players that are involved in the
By Product
By Type
By Distribution Channel
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed